Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry

Brain

Volumn 127, Issue 4, 2004, Pages 811-824

  Teipel, Stefan J ^a   Alexander, Gene E ^b,c   Schapiro, Marc B ^d   Möller, Hans Jürgen ^a   Rapoport, Stanley I ^e   Hampel, Harald ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ARIZONA STATE UNIVERSITY   (United States)

^c Arizona Alzheimer's Dis Core Center   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; Down's syndrome; Grey matter; Neocortex; Neurodegeneration

Indexed keywords

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CUNEATE NUCLEUS; DOWN SYNDROME; FEMALE; FRONTAL CORTEX; FRONTAL LOBE; GRAY MATTER; HUMAN; MALE; MORPHOMETRICS; NEOCORTEX; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; OLFACTORY CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; SUBICULUM; TEMPORAL LOBE;

ADULT; AGING; ALZHEIMER DISEASE; CEREBRAL CORTEX; COGNITION; DISEASE PROGRESSION; DOWN SYNDROME; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 1842683970     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh101     Document Type: Article

References (78)

1. Alexander GE, Saunders AM, Szczepanik J, Strassburger TL, Pietrini P, Dani A, et al. Relation of age and apolipoprotein E to cognitive function in Down syndrome adults. Neuroreport 1997; 8: 1835-40.
2. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am J Psychiatry 2002; 159: 738-45.
3. Ashburner J, Friston K. Multimodal image coregistration and partitioning - a unified framework. Neuroimage 1997; 6: 209-17.
4. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-21.
5. Ashburner J, Friston KJ. Why voxel-based morphometry should be used. Neuroimage 2001; 14: 1238-43.
6. Ashburner J, Neelin P, Collins DL, Evans A, Friston K. Incorporating prior knowledge into image registration. Neuroimage 1997; 6: 344-52.
7. Aylward EH, Li Q, Honeycutt NA, Warren AC, Pulsifer MB, Barta PE, et al. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. Am J Psychiatry 1999; 156: 564-8.
8. Azari NP, Pettigrew KD, Pietrini P, Horwitz B, Schapiro MB. Detection of an Alzheimer disease pattern of cerebral metabolism in Down syndrome. Dementia 1994; 5: 69-78.
9. Ball MJ, Nuttall K. Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down syndrome: quantitative comparison with Alzheimer dementia. Ann Neurol 1980; 7: 462-5.
10. Baron JC, Chételat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001; 14: 298-309.
11. Benson DF. Classical syndromes of aphasia. In: Boller F, Grafman J, editors. Handbook of neuropsychology, Vol. 1. Amsterdam: Elsevier; 1988. p. 267-80.
12. Bobinski M, de Leon MJ, Wegiel J, Desanti S, Convit A, Saint Louis LA, et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 2000; 95: 721-5.
13. Bookstein FL. Voxel-based morphometry should not be used with imperfectly registered images. Neuroimage 2001; 14: 1454-62.
14. Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci 2002; 3: 243-9.
15. Busatto GF, Garrido GE, Almeida OP, Castro CC, Camargo CH, Cid CG, et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease. Neurobiol Aging 2003; 24: 221-31.
16. Cabeza R, Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies. J Cogn Neurosci 2000; 12: 1-47.
17. Chételat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 2002; 13: 1939-43.
18. Connor JR, Menzies SL, St Martin SM, Mufson EJ. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res 1990; 27: 595-611.
19. Corbetta M, Shulman GL, Miezin FM, Petersen SE. Superior parietal cortex activation during spatial attention shifts and visual feature conjunction. Science 1995; 270: 802-5.
20. Dani A, Pietrini P, Furey ML, McIntosh AR, Grady CL, Horwitz B, et al. Brain cognition and metabolism in Down syndrome adults in association with development of dementia. Neuroreport 1996; 7: 2933-6.
21. DeLacoste MC, Kirkpatrick JB, Ross ED. Topography of the human corpus callosum. J Neuropathol Exp Neurol 1985; 44: 578-91.
22. delaMonte SM, Hedley-Whyte ET. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease. J Neuropathol Exp Neurol 1990; 49: 509-20.
23. DeLa Torre R, Casado A, Lopez-Fernandez E, Carrascosa D, Ramirez V, Saez J. Overexpression of copper-zinc superoxide dismutase in trisomy 21. Experientia 1996; 52: 871-3.
24. Duara R, Margolin RA, Robertson-Tchabo EA, London ED, Schwartz M, Renfrew JW, et al. Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. Brain 1983; 106: 761-75.
25. Dunn LM, Dunn LM. Peabody Picture Vocabulary Test-Revised. Circle Pines, MN: American Guidance Service; 1981.
26. Engidawork E, Lubec G. Protein expression in Down syndrome brain. Amino Acids 2001; 21: 331-61.
27. Evenhuis HM. The natural history of dementia in Down's syndrome. Arch Neurol 1990; 47: 263-7.
28. Fazekas F, Schmidt R, Kleinert R, Kapeller P, Roob G, Flooh E. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates. J Neural Transm Suppl 1998; 53: 31-9.
29. Friston K, Ashburner J, Frith CD, Poline J-B, Heather JD, Frackowiak RSJ. Spatial registration and normalization of image. Hum Brain Mapp 1995a; 3: 165-89.
30. Friston KJ, Holmes AP, Worsley KJ, Poline J-B, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995b; 2: 189-210.
31. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870-8.
32. Good CD, Johnsrude I, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage 2001a; 14: 685-700.
33. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001b; 14: 21-36.
34. Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage 2002; 17: 29-46.
35. Greicius MD, Krasnow B, Boyett-Anderson JM, Eliez S, Schatzberg AF, Reiss AL, et al. Regional analysis of hippocampal activation during memory encoding and retrieval: FMRI study. Hippocampus 2003; 13: 164-74.
36. Haxby JV. Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults. J Ment Defic Res 1989; 33: 193-210.
37. Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol 1995; 52: 379-91.
38. Ikeda M, Arai Y. Longitudinal changes in brain CT scans and development of dementia in Down's syndrome. Eur Neurol 2002; 47: 205-8.
39. Ishii K. Clinical application of positron emission tomography for diagnosis of dementia. Ann Nucl Med 2002; 16: 515-25.
40. Kesslak JP, Nagata SF, Lott I, Nalcioglu O. Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down's syndrome. Neurology 1994; 44: 1039-45.
41. Krasuski JS, Alexander GE, Horwitz B, Rapoport SI, Schapiro MB. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. Am J Psychiatry 2002; 159: 74-81.
42. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989; 46: 849-53.
43. Lawlor BA, McCarron M, Wilson G, McLoughlin M. Temporal lobe-oriented CT scanning and dementia in Down's syndrome. Int J Geriatr Psychiatry 2001; 16: 427-9.
44. Lee AC, Robbins TW, Owen AM. Episodic memory meets working memory in the frontal lobe: functional neuroimaging studies of encoding and retrieval. Crit Rev Neurobiol 2000; 14: 165-97.
45. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press; 1995.
46. Lott IT, Lai F. Dementia in Down's syndrome: observations from a neurology clinic. Appl Res Ment Retard 1982; 3: 233-9.
47. Mann DM. The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 1988; 43: 99-136.
48. Mann DM, Esiri MM. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 1989; 89: 169-79.
49. Mann DMA, Yates PO, Marcyniuk B. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 1984; 10: 185-207.
50. Mann DM, Yates PO, Marcyniuk B, Ravindra CR. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease. J Neurol Sci 1987; 80: 79-89.
51. Mann DM, Prinja D, Davies CA, Ihara Y, Delacourte A, Defossez A, et al. Immunocytochemical profile of neurofibrillary tangles in Down's syndrome patients of different ages. J Neurol Sci 1989; 92: 247-60.
52. Mielke R, Heiss WD. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia. J Neural Transm Suppl 1998; 53: 237-50.
53. Nagy Z, Jobst KA, Esiri MM, Morris JH, King EM-F, MacDonald B, et al. Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. Dementia 1996; 7: 76-81.
54. Pandya DN, Seltzer B. The topography of commissural fibres. In: Lepre F, Ptito M, Jasper HH, editors. Two hemispheres - one brain: functions of the corpus callosum. New York: Alan R. Liss; 1986. p. 47-73.
55. Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, et al. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. Am J Psychiatry 1997; 154: 1063-9.
56. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991; 12: 295-312.
57. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 2001; 58: 1395-402.
58. Raz N, Torres IJ, Briggs SD, Spencer WD, Thornton AE, Loken WJ, et al. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 1995; 45: 356-66.
59. Rondal JA, Comblain A. Language in ageing persons with Down syndrome. Downs Syndr Res Pract 2002; 8: 1-9.
60. Ross MH, Galaburda AM, Kemper TL. Down's syndrome: is there a decreased population of neurons? Neurology 1984; 34: 909-16.
61. Rugg MD, Otten LJ, Henson RN. The neural basis of episodic memory: evidence from functional neuroimaging. Philos Trans R Soc Lond B Biol Sci 2002; 357: 1097-110.
62. Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 1989; 320: 1446-52.
63. Sadowski M, Wisniewski HM, Tamawski M, Kozlowski PB, Lach B, Wegiel J. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology. Acta Neuropathol (Berl) 1999; 97: 156-64.
64. Schaltenbrand G, Spuer H, Wahren W. Electroanatomy of the corpus callosum radiation according to the facts of stereotactic stimulation in man. Z Neurol 1970; 198: 79-92.
65. Schapiro MB, Haxby JV, Grady CL, Duara R, Schlageter NL, White B, et al. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome. J Neurol Neurosurg Psychiatry 1987; 50: 766-74.
66. Schapiro MB, Ball MJ, Grady CL, Haxby JV, Kaye JA, Rapoport SI. Dementia in Down's syndrome: cerebral glucose utilization, neuropsychological assessment, and neuropathology. Neurology 1988; 38: 938-42.
67. Schapiro MB, Luxenberg JS, Kaye JA, Haxby JV, Friedland RP, Rapoport SI. Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different ages. Neurology 1989; 39: 1349-53.
68. Schapiro MB, Haxby JV, Grady CL. Nature of mental retardation and dementia in Down syndrome: study with PET, CT, and neuropsychology. Neurobiol Aging 1992; 13: 723-34.
69. Smith S. Fast robust automated brain extraction. Hum Brain Mapp 2002; 17: 143-55.
70. Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science 1991; 253: 1380-6.
71. Stevenson JD Jr. Alternate form reliability and concurrent validity of the PPVT-R for referred rehabilitation agency adults. J Clin Psychol 1986; 42: 650-3.
72. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme; 1988.
73. Teipel SJ, Schapiro MB, Alexander GE, Krasuski JS, Horwitz B, Hoehne C, et al. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. Am J Psychiatry 2003; 160: 1870-8.
74. Tyrrell J, Cosgrave M, McCarron M, McPherson J, Calvert J, Kelly A, et al. Dementia in people with Down's syndrome. Int J Geriatr Psychiatry 2001; 16: 1168-74.
75. White NS, Alkire MT, Haier RJ. A voxel-based morphometric study of nondemented adults with Down syndrome. Neuroimage 2003; 20: 393-403.
76. Wisniewski KE, Dalton AJ, McLachlan C, Wen GY, Wisniewski HM. Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology 1985a; 35: 957-61.
77. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985b; 17: 278-82.
78. Yamada K, Gonzalez RG, Ostergaard L, Komili S, Weisskoff RM, Rosen BR, et al. Iron-induced susceptibility effect at the globus pallidus causes underestimation of flow and volume on dynamic susceptibility contrast-enhanced MR perfusion images. AJNR Am J Neuroradiol 2002; 23: 1022-9.